Wang Xiaoqi

Wang Xiaoqi

Auto-generated profile, based on publicly available information

Wang Xiaoqi

Hunan University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2021 in Bioinformatics
Verified
Journal Article
Closed access
PDF file
XWXiaoqi Wang
Xiaoqi Wang
YYYaning Yang
Yaning Yang
KLKenli Li
Kenli Li
WLWentao Li
Wentao Li
FLFei Li
Fei Li
XZXiaoyu Zhang
Xiaoyu Zhang
Predicting entity relationship can greatly benefit important biomedical problems. Recently, a large amount of biomedical heterogeneous networks (BioHNs) are generated and offer opportunities for developing network-based learning approaches to predict relationships among entities. However, current researches slightly explored BioHNs-based self-supervised representation learning methods, and are hard to simultaneously capturing local- and global-level association information among entities. In this study, we propose a BioHN-based self-supervised representation learning approach for entity relationship predictions, termed BioERP. A self-supervised meta path detection mechanism is proposed to train a deep Transformer encoder model that can capture the global structure and semantic feature in BioHNs. Meanwhile, a biomedical entity mask learning strategy is designed to reflect local associations of vertices. Finally, the representations from different task models are concatenated to generate two-level representation vectors for predicting relationships among entities. The results on eight datasets show BioERP outperforms 30 state-of-the-art methods. In particular, BioERP reveals great performance with results close to 1 in terms of AUC and AUPR on the drug–target interaction predictions. In summary, BioERP is a promising bio-entity relationship prediction approach. Source code and data can be downloaded from https://github.com/pengsl-lab/BioERP.git. Supplementary data are available at Bioinformatics online.

9 February 2022 in Research Square
Verified
Preprint
Open access
PDF file
XWXiaoqi Wang
Xiaoqi Wang
YCYingjie Cheng
Yingjie Cheng
YYYaning Yang
Yaning Yang
FLFei Li
Fei Li
XZXiaoyu Zhang
Xiaoyu Zhang
Self-supervised representation learning (SSL) on biomedical networks provides new opportunities for drug discovery that lacks available biology or clinic phenotype. However, how to effectively combine multiple SSL models is still challenging and has been rarely explored. Therefore, we propose multi-task joint strategies of self-supervised representation learning on biomedical networks for drug discovery, named MSSL2drug. We design six basic SSL tasks inspired by various modality features including structures, semantics, and attributes in heterogeneous biomedical networks. In addition, fifteen combinations of multiple tasks are evaluated by a graph attention-based adversarial multi-task learning framework in two drug discovery scenarios. The results suggest two important findings. (1) Combinations of multimodal tasks achieve the best performance compared to other multi-task joint strategies. (2) The joint training of local and global SSL tasks yields higher performance than random task combinations. Therefore, we conjecture that the multimodal and local-global combination strategies can be treated as a guideline of multi-task SSL for drug discovery.

24 June 2020 in ChemRxiv
Verified
Preprint
Open access
PDF file
WXWang Xiaoqi
Wang Xiaoqi
BXBin Xin
Bin Xin
Zhijian XuZhijian Xu
Zhijian Xu
KLKenli Li
Kenli Li
FLFei Li
Fei Li
SPShaoliang Peng
Shaoliang Peng
Recent studies have been demonstrated that host immune imbalance is an important factors leading to acute respiratory distress syndrome (ARDS) in COVID-19 patients. Therefore, discovery of potential drugs and identification of their mechanisms of action for the prevention of immune imbalance in COVID-19 patients are urgently needed. In this study, we proposed a network representation learning-based methodology, termed AIdrug2cov, to discover drug mechanism and anti-inflammatory response for patients with COVID19. In AIdrug2cov, a deep bidirectional Transformer encoder network representation approach is developed to automatically learn lowdimensional vector of heterogeneous network. Using the representation vectors, AIdrug2cov identifies 40 potential targets and 24 high-confidence drugs that bind to tumor necrosis factor(TNF)-α or interleukin(IL)-6 to prevent excessive inflammatory responses in COVID-19 patients. In particular, AIdrug2cov indicated that chloroquine and hydroxychloroquine are able to reduce fatality of COVID-19 patients, and that their mechanisms of action are likely mediated through their inhibition of inflammatory cytokines on top of their antiviral ability, consistent with the findings of clinical studies. In addition, the results in 5 pharmacological application suggested that AIdrug2cov significantly outperforms 5 other state-of-the-art network representation approaches, future demonstrating the availability of AIdrug2cov in drug development field. In summary, AIdrug2cov is practically useful for accelerating COVID-19 therapeutic development. The source code and data can be downloaded from https://github.com/pengsl-lab/AIdrug2cov.git

26 June 2020 in ChemRxiv
Verified
Preprint
Open access
PDF file
WXWang Xiaoqi
Wang Xiaoqi
BXBin Xin
Bin Xin
Zhijian XuZhijian Xu
Zhijian Xu
KLKenli Li
Kenli Li
FLFei Li
Fei Li
SPShaoliang Peng
Shaoliang Peng
Recent studies have been demonstrated that host immune imbalance is an important factors leading to acute respiratory distress syndrome (ARDS) in COVID-19 patients. Therefore, discovery of potential drugs and identification of their mechanisms of action for the prevention of immune imbalance in COVID-19 patients are urgently needed. In this study, we proposed a network representation learning-based methodology, termed AIdrug2cov, to discover drug mechanism and anti-inflammatory response for patients with COVID19. In AIdrug2cov, a deep bidirectional Transformer encoder network representation approach is developed to automatically learn lowdimensional vector of heterogeneous network. Using the representation vectors, AIdrug2cov identifies 40 potential targets and 24 high-confidence drugs that bind to tumor necrosis factor(TNF)-α or interleukin(IL)-6 to prevent excessive inflammatory responses in COVID-19 patients. In particular, AIdrug2cov indicated that chloroquine and hydroxychloroquine are able to reduce fatality of COVID-19 patients, and that their mechanisms of action are likely mediated through their inhibition of inflammatory cytokines on top of their antiviral ability, consistent with the findings of clinical studies. In addition, the results in 5 pharmacological application suggested that AIdrug2cov significantly outperforms 5 other state-of-the-art network representation approaches, future demonstrating the availability of AIdrug2cov in drug development field. In summary, AIdrug2cov is practically useful for accelerating COVID-19 therapeutic development. The source code and data can be downloaded from https://github.com/pengsl-lab/AIdrug2cov.git